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Abstract The conjunctiva’s bacterial profile at birth and 1 week after Crede´’s gonoccocal ophthalmic prophylaxis
was evaluated over a 3-month period using culture and direct immunofluorescence. Thirty-four neonates received
10% silver vitellinate and 42 sterile saline. Chlamydia trachomatis was recovered in 7/34 and 9/42 neonates receiving
silver vitellinate and saline at birth and in 8/34 and 12/42 after 1 week, respectively. Neisseria gonorrhoeae was not
identified. Crede´’s may not be the ideal prophylactic method in areas with a low prevalence of N. gonorrhoeae.
Introduction
Since its introduction in 1881, Crede´’s
method of reducing neonatal ophthalmia
has been used worldwide.1 It requires the
instillation of one drop of 1% silver nitrate
(AgNO3) at birth but is often followed by
chemical conjunctivitis. Although alterna-
tive solutions such as silver vitellinate,
tetracycline or erythromycin2,3 are reported
to be less effective, the low incidence of
gonoccocal ophthalmia in many settings
encourages services to change their proto-
cols.4,5 There are no recent studies describ-
ing the side-effects of silver vitellinate. In
populations with a low incidence of gonoc-
cocal ophthalmia, the changes in the ocular
flora associated with its use might be
different from those reported in high-
incidence populations. This study describes
the bacterial conjunctival profile of neonates
receiving silver vitellinate at birth and 1
week after birth and compares these changes
with a group of neonates receiving ocular
toilette with sterile saline.
Methods
This descriptive study of neonates was
conducted in a maternity hospital in
Aracaju, Brazil. The incidence of gonoccocal
ophthalmia in this setting is very low (,1%),
while the incidence of Chlamydia trachomatis
is unknown. The hospital guidelines advise
the use of 1% silver nitrate for all newborns.
Owing to procurement problems, however,
the hospital was not employing prophylaxis
at the time of the study. After obtaining
maternal informed consent, neonates were
randomised to receive either one drop of
10% silver vitellinate (ArgyrolH Laboratories,
Allergan Frumtost) or saline solution in both
eyes soon after birth and when the child was
stable.
Two conjunctival specimens were col-
lected within the 1st 2 hours of life and
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before any cleaning or eye instillations.
Specimens were collected by rolling cotton
swabs on the inferior corner of the conjunc-
tiva using a standardised technique.6 They
were cultured on several media for aerobic
and anaerobic bacteria including enriched
chocolate agar6 and examined for C. tracho-
matis using a direct immunofluorescence
(DIF) test.7 Participants were then followed
1 week later at their home or health centre
when two further swabs were collected.
Analysis
The proportions of cultures and DIF tests
that were positive on enrolment and follow-
up were compared by treatment group using
the x2 test with Yates’ correction or
Fischer’s Exact test, where appropriate.
The study protocol was approved by the
Research Ethics Committee of the Federal
University of Sergipe, Brazil.
Results
A total of 76 newborns were enrolled from
March to May 2006 (Table 1). Of these, 34
received silver vitellinate and 42 received
saline. Twenty-nine infants using silver
vitellinate and 17 using saline were followed
1 week later. Ten (29%) and three (7%)
children receiving silver vitellinate and
saline, respectively, had positive cultures
on enrolment (p50.02). Similarly, seven
(20%) and nine (21%) of the children
receiving silver vitellinate and saline, respec-
tively, had a positive DIF for C. trachomatis
on enrolment. Positive cultures were recov-
ered more frequently during follow-up, and
had increased from 13 (38%) to 35 (93%) 1
week later (p,0.001). C. trachomatis was
still the most frequently detected micro-
organism 1 week later (23% in the silver
vitellinate and 31% in the saline groups).
Many infants had discordant DIF results on
follow-up, with nine of 42 specimens testing
negative at birth and positive 1 week later
(Table 1). The proportions of infants with
positive cultures and DIF results did not
differ by treatment group.
The profile for the two collections
included Staphylococus aureus (5% and
21%), Staphylococcus epidermidis (0% and
17%), micrococcus spp (5% and 0%)
TABLE 1. Bacterial culture and Chlamydia trachomatis direct immunofluorescence (DIF) results at birth and
after 1 week follow-up by treatment group.
Vitellinate group Saline group
Culture on follow-up
Positive Negative Missing Total Positive Negative Missing Total
Culture at birth
Positive 7 3 – 10 1 1 1 3
Negative 16 4 2 22 11 4 – 15
Missing 2 – – 2 3 – 21 24
Total 25 7 2 34 15 5 22 42
DIF on follow-up
Positive Negative Missing Total Positive Negative Missing Total
DIF at birth
Positive 4 1 2 7 7 8 1 9
Negative 4 17* 6 27 5 16 – 21
Missing – – – – – 2 3 5
Total 8 18 8 34 12 26 1 42
* Fisher Exact test, p50.02.
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and gram-negative bacteriae (5% and 5%).
N. gonorrhoeae was not found. Negative
samples decreased from 62% to 19%
(Table 2).
Discussion
C. trachomatis is the bacterium most fre-
quently found in children with clinical signs
of neonatal ophthalmia, even in areas such
as sub-Saharan Africa where N. gonorrhoeae
is still prevalent.8 This bacterium, while still
common in some regions, is rare in Latin
America (,1% in most places)2 and,
because silver nitrate produces chemical
conjunctivitis and is ineffective against C.
trachomatis, alternative solutions for pre-
venting neonatal ophthalmia are increas-
ingly being used.8
During the 3 months of data collection,
no cases of N. gonorrhoea were detected.
Bacterial colonisation increased and in both
groups its profile changed after 1 week.
Staphylococcus aureus and Staph. epidermidis
had increased colonisation after 1 week and
C. trachomatis was the most frequently
detected bacterium in both groups at birth
and during follow-up. Silver nitrate and
silver vitellinate are both ineffective against
C. trachomatis, although the latter produces
less chemical conjunctivitis. Whether the
Crede´ method is still suitable in locations
with very low N. gonorrhoeae prevalence is
now in question, although alternative
solutions are not effective against the most
common aetiological agents.8 Furthermore,
some of these solutions include antibiotics
which might induce bacterial resistance or
patient sensitisation.
Regular antenatal care, starting during
early pregnancy, and screening for sexually
transmitted diseases (STD) reduce the
number and severity of cases of neonatal
ophthalmia.2 The World Health Organiza-
tion proposes a syndromic approach for
screening for STDs and for treating sugges-
tive case empirically, thus reducing the risk
of infection during and after delivery.9
Brazil is a large country with many
disparities in healthcare provision and
socio-economic conditions, but women
there have relatively good access to antena-
tal care. In Aracaju, it is reported that 89%
of mothers attend antenatal care in public
healthcare facilities and that good preventive
practices including HIV/STD testing at
birth are being implemented.10
The Crede´ method did not affect the
results of culture and DIF. As it frequently
leads to chemical conjunctivitis, it may be
unnecessary in places such as Aracaju where
there is a low prevalence of N. gonorrhoeae
and cases can be treated as they are
diagnosed. This might not be the case
elsewhere (such as some areas of sub-
Saharan Africa and Asia) where the pre-
valence of N. gonorrhoeae is high and
preventive strategies are required for C.
trachomatis and N. gonorrhoeae.
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